JPS557287A - Aryloxypropanol amine - Google Patents

Aryloxypropanol amine

Info

Publication number
JPS557287A
JPS557287A JP8028779A JP8028779A JPS557287A JP S557287 A JPS557287 A JP S557287A JP 8028779 A JP8028779 A JP 8028779A JP 8028779 A JP8028779 A JP 8028779A JP S557287 A JPS557287 A JP S557287A
Authority
JP
Japan
Prior art keywords
aryloxypropanol
amine
aryloxypropanolamines
pharmaceuticals
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP8028779A
Other languages
English (en)
Inventor
Jiee Boorudouin Jiyon
Ii Makukuruua Deibuitsudo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of JPS557287A publication Critical patent/JPS557287A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/64—One oxygen atom attached in position 2 or 6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/68—One oxygen atom attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/24—Ethers with hydroxy compounds containing no oxirane rings with polyhydroxy compounds
    • C07D303/26—Ethers with hydroxy compounds containing no oxirane rings with polyhydroxy compounds having one or more free hydroxyl radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP8028779A 1978-06-27 1979-06-27 Aryloxypropanol amine Pending JPS557287A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/919,593 US4210653A (en) 1978-06-27 1978-06-27 Pyridyloxypropanolamines

Publications (1)

Publication Number Publication Date
JPS557287A true JPS557287A (en) 1980-01-19

Family

ID=25442346

Family Applications (1)

Application Number Title Priority Date Filing Date
JP8028779A Pending JPS557287A (en) 1978-06-27 1979-06-27 Aryloxypropanol amine

Country Status (6)

Country Link
US (1) US4210653A (ja)
EP (1) EP0006614B1 (ja)
JP (1) JPS557287A (ja)
AT (1) ATE4707T1 (ja)
DE (1) DE2966179D1 (ja)
DK (1) DK267979A (ja)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59209626A (ja) * 1983-05-13 1984-11-28 Gadelius Kk バグフイルタ−
US4531258A (en) * 1984-05-22 1985-07-30 Stanley Spellman Refuse bag frame for vacuum cleaners
JPH06170136A (ja) * 1992-12-04 1994-06-21 Hitachi Zosen Corp 乾式集塵器のバグリテーナ
WO1999025458A1 (en) * 1997-11-14 1999-05-27 Albany International Corp. A modular filter bag cage

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL62602A (en) * 1980-05-19 1984-06-29 Labaz Sanofi Nv Pyridoxine derivatives,their preparation and pharmaceutical compositions containing them
US4348398A (en) * 1980-12-23 1982-09-07 Merck Sharp & Dohme (I.A.) Corp. Quinolinyl ethanolamines
IL65541A0 (en) * 1981-05-06 1982-07-30 Haessle Ab Alkylamino-2-propanols,process for their preparation and pharmaceutical preparations containing same
JPS57188570A (en) * 1981-05-14 1982-11-19 Shionogi & Co Ltd Benzylazole derivative
JPS5988467A (ja) * 1982-11-09 1984-05-22 Yoshitomi Pharmaceut Ind Ltd フエノキシアミノプロパノ−ル誘導体
JPS60158153A (ja) * 1984-01-12 1985-08-19 イーライ・リリー・アンド・カンパニー 変力剤
GB8510146D0 (en) * 1985-04-20 1985-05-30 Smith Kline French Lab Chemical compounds & processes
US5153338A (en) * 1986-06-25 1992-10-06 Massachusetts Institute Of Technology Optically active derivatives of glycidol
US4946974A (en) * 1986-10-01 1990-08-07 Massachusetts Institute Of Technology Optically active derivatives of glycidol
WO1988000190A1 (en) * 1986-06-25 1988-01-14 Massachusetts Institute Of Technology Optically active derivatives of glycidol
FR2638747B1 (fr) * 1988-11-08 1993-12-24 Synthelabo Derives de phenyloxypropanolamines, leur preparation et leur application en therapeutique
ES2069137T3 (es) * 1990-07-30 1995-05-01 Takeda Chemical Industries Ltd Derivados de imidazopiridina y su uso.

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1136919A (en) * 1965-06-16 1968-12-18 Ici Ltd Amines
SE378102B (ja) * 1969-11-28 1975-08-18 Teikoku Hormone Mfg Co Ltd
AR207133A1 (es) * 1973-02-20 1976-09-15 Ciba Geigy Ag Procedimiento para la elaboracion de derivados de 1-piridiloxi 1-pirimidiniloxi y 1-piraziniloxi-2-hidroxi-3-amino-propano
US4088764A (en) * 1973-12-27 1978-05-09 Cassella Farbwerke Mainkur Aktiengesellschaft Pharmaceutically active derivatives of 1-phenoxy-3-amino-propan-2-ol
SE388849B (sv) * 1974-02-14 1976-10-18 Haessle Ab Forfarande for framstellning av nya aminer med beta-receptorstimulerande verkan
CH594626A5 (ja) * 1974-05-14 1978-01-13 Ciba Geigy Ag
CH586717A5 (en) * 1974-12-10 1977-04-15 Ciba Geigy Ag Optically active derivs. of (1)-phenoxy-(2)-hydroxy-(3)-amino-propane - stimulate cardiac beta-receptors, contg. alkanoylated or benzoylated sugar residue
CH618958A5 (en) * 1975-07-01 1980-08-29 Ciba Geigy Ag Process for the preparation of novel secondary acyloxyamines
CH607585A5 (en) * 1976-10-05 1978-09-15 Ciba Geigy Ag Process for the preparation of 2-[3'-(2-(3,4-dimethoxy-phenyl)ethylamino)-2'-hydroxypropoxy]-3-cyanop yridine
US4166851A (en) * 1977-05-16 1979-09-04 Merck & Co., Inc. Certain imidazo(1,2a)pyridine derivatives

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59209626A (ja) * 1983-05-13 1984-11-28 Gadelius Kk バグフイルタ−
US4531258A (en) * 1984-05-22 1985-07-30 Stanley Spellman Refuse bag frame for vacuum cleaners
JPH06170136A (ja) * 1992-12-04 1994-06-21 Hitachi Zosen Corp 乾式集塵器のバグリテーナ
WO1999025458A1 (en) * 1997-11-14 1999-05-27 Albany International Corp. A modular filter bag cage
US5951726A (en) * 1997-11-14 1999-09-14 Albany International Corp. Modular filter bag cage

Also Published As

Publication number Publication date
DK267979A (da) 1980-01-28
DE2966179D1 (en) 1983-10-27
US4210653A (en) 1980-07-01
ATE4707T1 (de) 1983-10-15
EP0006614A3 (en) 1980-01-23
EP0006614A2 (en) 1980-01-09
EP0006614B1 (en) 1983-09-21

Similar Documents

Publication Publication Date Title
IL56774A0 (en) Arylsulfamates,their preparation and their use as hermicid
IL57794A0 (en) 2-chloro-6-nitroaniline derivatives,their preparation and their use as herbicides
FI830378A7 (fi) Pyratsolioksatsiinit, -tiatsiinit, - kinoliinit, menetelmä niiden valmistamiseksi ja niiden käyttö lääkeainlääkeaineina.
DE2966179D1 (en) Pyridyl- and imidazopyridyloxypropanolamines, process for preparing the same and pharmaceutical compositions containing the same
IL57430A0 (en) Carbamimidothioates,their preparation and their use as herbicides
IL56882A0 (en) Acylated1-azolyl-2-hydroxy-butane derivatives,their preparation and their use asfungicides
IL56614A (en) N-azolylalkyl-halogeno-acetanilides,their preparation and their use as herbicides
TR20548A (tr) 1,2,3-tiyadiyazel-5-yil uerelerin imalline mahsus usul
ZA794885B (en) N-benzylhaloacetamide derivatives,and their production and use
DE3173396D1 (en) Tridecapeptide, process for its preparation and its use
ZA796022B (en) N-phenylureas,processes for their preparation and their use as herbicides
DE2960021D1 (en) Acyloxy-2-butenes, their preparation and their use for the preparation of 4-acetoxytiglinaldehyde
ZA795815B (en) Substituted n-propargyl-anilines,processes for their preparation and their use as fungicides
IL56348A0 (en) Novel phenoxyalkylocazolines, their preparation and their use as herbicides
DE2967095D1 (en) Phenyliminomethyl-3-pyridine derivatives, their preparation and use
DE2966446D1 (en) Beta-lactam compounds, their preparation and use
ZA7945B (en) Novel carbamoyl-triazolyl-o,n-acetals,processes for their preparation and their use as fungicides
IL56728A0 (en) Novel androstadienes,their preparation and their use as dermatological agents
FI800350A7 (fi) Dehydropeptidejä, menetelmiä niiden valmistamiseksi sekä niiden käyttö lääkeaineina.
IL56484A0 (en) Novel phenoxyalkyloxazolines, their preparation and their use as herbicides
RO76486A (ro) Procedeu pentru prepararea unor 2,6-dinitrobenzenamine
DE2960134D1 (en) 1-hydroxymethylimidazoles, their preparation and use as chemical intermediates
DE2962151D1 (en) Bis-n-dialkylcarbamyl-quinacridones, process for their preparation and their application
EP0005756A3 (en) 5-arylamino-2,2-difluoro-benzodioxolanes, process for their preparation, and their use as pesticides
ZA794348B (en) N-(o-ethyl-s-n-propyl-(di)thiophosphoryloxy)-naphthalimides process for their preparation,and their use as pesticides